Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$183M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Mehra Anand | Nov 19, 2024 | Buy | 666,666 | $2.25 | $1.5M |
| Leonard Braden Michael | Aug 5, 2024 | Buy | 206,025 | $1.2443 | $260,000 |
| Leonard Braden Michael | Aug 2, 2024 | Buy | 167,544 | $1.2916 | $220,000 |
| Leonard Braden Michael | Jul 31, 2024 | Buy | 100,000 | $1.3264 | $130,000 |
| Leonard Braden Michael | Jul 30, 2024 | Buy | 173,730 | $1.303 | $230,000 |
| Leonard Braden Michael | Jul 22, 2024 | Buy | 17,716 | $1.3297 | $24,000 |
| Leonard Braden Michael | Jul 19, 2024 | Buy | 6,689 | $1.3 | $8,700 |
| Leonard Braden Michael | Jul 18, 2024 | Buy | 130,317 | $1.3011 | $170,000 |
| Leonard Braden Michael | Jul 5, 2024 | Buy | 123,017 | $1.1489 | $140,000 |
| Leonard Braden Michael | Jul 3, 2024 | Buy | 143,288 | $1.159 | $170,000 |
| Leonard Braden Michael | Jul 2, 2024 | Buy | 86,092 | $1.144 | $98,000 |
| Leonard Braden Michael | Jul 1, 2024 | Buy | 107,434 | $1.1373 | $120,000 |
| Leonard Braden Michael | Jun 28, 2024 | Buy | 801,000 | $1.1193 | $900,000 |
| Leonard Braden Michael | Jun 28, 2024 | Buy | 400,000 | $1.13 | $450,000 |
| Leonard Braden Michael | Jun 27, 2024 | Buy | 235,000 | $1.1546 | $270,000 |
| Leonard Braden Michael | Jun 18, 2024 | Buy | 50,000 | $1.1301 | $57,000 |
| Leonard Braden Michael | Jun 17, 2024 | Buy | 150,000 | $1.13 | $170,000 |
| Leonard Braden Michael | Jun 14, 2024 | Buy | 345,000 | $1.1658 | $400,000 |
| Leonard Braden Michael | Jun 13, 2024 | Buy | 500,000 | $1.15 | $580,000 |
| Leonard Braden Michael | Jun 13, 2024 | Buy | 28,621 | $1.1445 | $33,000 |
| Leonard Braden Michael | Jun 12, 2024 | Buy | 82,579 | $1.14 | $94,000 |
| Leonard Braden Michael | Jun 11, 2024 | Buy | 1,000,000 | $1.08 | $1.1M |
| Powell Andrew Kenneth William | Mar 4, 2024 | Buy | 6,000 | $1.25 | $7,500 |
| Powell Andrew Kenneth William | Mar 1, 2024 | Buy | 8,500 | $1.23 | $10,000 |
| Monahan Joseph | Oct 23, 2023 | Sell | 6,000 | $5.0767 | $30,000 |
| Balthaser Kevin | Sep 6, 2023 | Buy | 9,490 | $7.9 | $75,000 |
| Loerop James | Aug 28, 2023 | Buy | 14,705 | $6.7976 | $100,000 |
| Monahan Joseph | Aug 21, 2023 | Sell | 6,000 | $7.3158 | $44,000 |
| Monahan Joseph | Jun 20, 2023 | Sell | 6,000 | $10.2771 | $62,000 |
| Manion Douglas J. | Mar 17, 2023 | Buy | 6,300 | $7.8623 | $50,000 |
| Manion Douglas J. | Mar 9, 2023 | Buy | 6,500 | $7.735 | $50,000 |
| Walker Neal | Mar 3, 2023 | Sell | 30,240 | $12.6346 | $380,000 |
| Monahan Joseph | Mar 3, 2023 | Sell | 16,037 | $12.6342 | $200,000 |
| Balthaser Kevin | Mar 3, 2023 | Sell | 894 | $12.6281 | $11,000 |
| Walker Neal | Mar 2, 2023 | Sell | 29,000 | $12.3651 | $360,000 |
| Monahan Joseph | Mar 2, 2023 | Sell | 14,800 | $12.3665 | $180,000 |
| Balthaser Kevin | Mar 2, 2023 | Sell | 1,000 | $12.289 | $12,000 |
| Monahan Joseph | Feb 15, 2023 | Sell | 5,000 | $13.0621 | $65,000 |
| Loerop James | Feb 8, 2023 | Sell | 4,267 | $13.8909 | $59,000 |
| Walker Neal | Feb 2, 2023 | Sell | 3,121 | $16.8827 | $53,000 |
| Walker Neal | Feb 2, 2023 | Sell | 1,079 | $14.5671 | $16,000 |
| Walker Neal | Feb 2, 2023 | Sell | 600 | $15.5533 | $9,300 |
| Walker Neal | Feb 2, 2023 | Sell | 200 | $17.535 | $3,500 |
| Walker Neal | Feb 1, 2023 | Sell | 25,000 | $16.747 | $420,000 |
| Walker Neal | Jan 4, 2023 | Sell | 15,000 | $14.8895 | $220,000 |
| Walker Neal | Jan 3, 2023 | Sell | 23,382 | $15.1855 | $360,000 |
| Walker Neal | Jan 3, 2023 | Sell | 1,618 | $16.1594 | $26,000 |
| Monahan Joseph | Dec 15, 2022 | Sell | 5,000 | $15.8823 | $79,000 |
What's the latest insider transaction for Aclaris Therapeutics?
The most recent insider transaction for Aclaris Therapeutics was conducted by Mehra Anand, who sold 666,666 shares on November 19, 2024 at a price of $2.25 per share.
Which insider bought the most ACRS stock over the last two years?
Leonard Braden Michael has bought the most ACRS stock in the last 2 years, with a total value of $5.6M.
Which insider has sold the most ACRS stock over the last two years?
Walker Neal has sold the most ACRS stock in the last 2 years, with a total value of $1.8M.
What is the total value of insider transactions for Aclaris Therapeutics (ACRS) in the last 2 years?
According to our estimates, the total value of insider transactions for Aclaris Therapeutics in the last 2 years is positive, amounting to $4.8M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Aclaris Therapeutics' market confidence?
Over the last 2 years, insider transactions for Aclaris Therapeutics have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
